EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial

Tulio Caldonazo iD, Mohamed Rahouma iD, Sigrid Sandner iD, Bjorn Redfors iD, Lamia Harik, Markus Richter, Hristo Kirov iD, Torsten Doenst iD, Mario F L Gaudino iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.040848 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Tulio Caldonazo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery Jena University Hospital, Friedrich-Schiller-University Jena Germany. Hauptthemen laut MEDLINE: Coronary Artery Disease, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The fibrosis‐4 index (FIB‐4) score, a noninvasive marker of subclinical liver fibrosis, has shown prognostic utility in general surgical populations. Current risk assessment models for patients with coronary artery disease undergoing percutaneous coronary intervention or coronary artery bypass grafting do not account for liver dysfunction apart from overt liver cirrhosis. We analyzed the distribution of the baseline FIB‐4 score and its association with all‐cause death in patients with coronary artery disease using data from the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial.

Methods

The baseline FIB‐4 score was calculated for all ISCHEMIA randomized participants with laboratory data (platelet count, aspartate aminotransferase, and alanine aminotransferase). The primary outcome was the association between baseline FIB‐4 and all‐cause death. Secondary outcomes were cardiovascular death, heart failure, myocardial infarction, and stroke. Multivariable Cox regression was performed adjusting for key risk factors.

Results

The FIB‐4 score was calculated for 3735 participants. Baseline FIB‐4 score was significantly associated with an increased risk of all‐cause (hazard ratio [HR], 1.19 [95% CI, 1.07–1.32]; P =0.001) and cardiovascular death (HR, 1.19 [95% CI, 1.04–1.36]; P =0.011). This association was consistent across the overall population and within subgroups of patients treated with percutaneous coronary intervention, coronary artery bypass grafting, and medical therapy. There was no significant association regarding heart failure, myocardial infarction, and stroke.

Conclusions

The FIB‐4 score may be a significant predictor of death in patients with coronary artery disease. Preprocedural hepatic assessment should be considered to stratify risk in patients undergoing invasive cardiac procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseLiver CirrhosisHumansMaleFemaleMiddle AgedAgedRisk AssessmentRisk FactorsPercutaneous Coronary InterventionCoronary Artery BypassCause of DeathAsymptomatic DiseasesAspartate AminotransferasesBiomarkersAlanine TransaminasePrognosisPlatelet Count

Stichwörter der Autor:innen

chronic coronary artery diseasecoronary artery bypass grafting (CABG)liver fibrosismedical therapypercutaneous coronary intervention (PCI)

Substanzen

Aspartate AminotransferasesBiomarkersAlanine Transaminase

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery Jena University Hospital, Friedrich-Schiller-University Jena Germany.
  • Department of Cardiothoracic Surgery Weill Cornell Medicine New York NY USA.
  • Department of Cardiac Surgery Medical University of Vienna Vienna Austria.
  • Department of Population Health Sciences Weill Cornell Medicine New York NY USA.
  • Department of Molecular and Clinical Medicine Institute of Medicine, Gothenburg University Gothenburg Sweden.
  • Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden.

ORCID-Profile: Tulio Caldonazo, Mohamed Rahouma, Sigrid Sandner, Bjorn Redfors, Hristo Kirov, Torsten Doenst, Mario F L Gaudino

Zitieren

APA

Caldonazo, T., Rahouma, M., Sandner, S., Redfors, B., Harik, L., Richter, M., Kirov, H., Doenst, T., & Gaudino, M. F. L. (2025). Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040848

Vancouver

Caldonazo T, Rahouma M, Sandner S, Redfors B, Harik L, Richter M, et al. Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040848

BibTeX
@article{Caldonazo2025,
  author = {Caldonazo, Tulio and Rahouma, Mohamed and Sandner, Sigrid and Redfors, Bjorn and Harik, Lamia and Richter, Markus and Kirov, Hristo and Doenst, Torsten and Gaudino, Mario F L},
  title = {Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.040848}
}
Kostenlos starten →